In contrast, the rate of human epidermal growth factor receptor 2 (HER2) positivity in MBC patients is lower than that in female breast cancer patients [4,5]. A radical mastectomy is usually the treatment of choice. This evidence concerns the gene ERBB2 and breast cancer.